[HTML][HTML] Emerging role of exosomes in cancer progression and tumor microenvironment remodeling

MDA Paskeh, M Entezari, S Mirzaei, A Zabolian… - Journal of hematology & …, 2022 - Springer
Cancer is one of the leading causes of death worldwide, and the factors responsible for its
progression need to be elucidated. Exosomes are structures with an average size of 100 nm …

Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell‐Derived Exosomes in Cell‐Free Therapy

S Chen, F Sun, H Qian, W Xu, J Jiang - Stem cells international, 2022 - Wiley Online Library
Mesenchymal stem cells (MSCs) have been widely applied to regenerative medicine owing
to their multiple differentiation, self‐renewal, and immunomodulatory abilities. Exosomes are …

[HTML][HTML] Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application

DN Kumar, A Chaudhuri, F Aqil, D Dehari, R Munagala… - Cancers, 2022 - mdpi.com
Simple Summary Breast cancer is considered the second most occurring cancer after lung
cancer globally. The treatment for breast cancer includes surgery, radiation, chemotherapy …

Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through the NLRP3 signaling pathway

Y Wang, J Liu, H Wang, S Lv, Q Liu, S Li, X Yang… - Stem …, 2023 - academic.oup.com
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide.
Exosomes (Exo) derived from human umbilical cord mesenchymal stem cells (HUC-MSCs) …

[HTML][HTML] Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer

A Dalmizrak, O Dalmizrak - Frontiers in Bioengineering and …, 2022 - frontiersin.org
Although ongoing medical research is working to find a cure for a variety of cancers, it
continues to be one of the major causes of death worldwide. Chemotherapy and …

[HTML][HTML] Tumor-derived exosomes and their role in breast cancer metastasis

S Huang, M Dong, Q Chen - International journal of molecular sciences, 2022 - mdpi.com
Breast cancer has been the most common cancer in women worldwide, and metastasis is
the leading cause of death from breast cancer. Even though the study of breast cancer …

[HTML][HTML] Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis

D Brena, MB Huang, V Bond - Translational oncology, 2022 - Elsevier
Breast cancer metastatic progression to critical secondary sites is the second leading cause
of cancer-related mortality in women. While existing therapies are highly effective in …

[HTML][HTML] Mesenchymal stem cell-derived extracellular vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity

C Shan, Y Liang, K Wang, P Li - International Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Mesenchymal stem cells (MSCs) are a type of stromal cells characterized by their properties
of self-renewal and multi-lineage differentiation, which make them prominent in regenerative …

[HTML][HTML] Shining the light on mesenchymal stem cell-derived exosomes in breast cancer

GRL Al-Awsi, F Alsaikhan, R Margiana, I Ahmad… - Stem Cell Research & …, 2023 - Springer
In women, breast cancer (BC) is the second most frequently diagnosed cancer and the
leading cause of cancer death. Mesenchymal stem cells (MSCs) are a subgroup of …

Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano …

R Kou, T Li, C Fu, D Jiang, Y Wang, J Meng… - Environmental …, 2024 - Elsevier
Although bone marrow mesenchymal stem cells (BM-MSCs)-derived exosomes have been
reported to be closely associated with acute myeloid leukemia (AML) progression and …